With over 30 years of experience and research, DXN focuses on Ganoderma (Lingzhi), a prized type of mushroom known in traditional Far Eastern practices. We use only carefully selected, high-quality Ganoderma in our products.

Our Ganoderma and other botanicals are processed and manufactured in certified GMP (Good Manufacturing Practices) facilities in Alor Setar, Kedah, Malaysia. This means our products are manufactured under stringent quality standards.

At DXN, we believe in the power of nature and the quality of raw materials, and we strive to ensure that our products complement a varied lifestyle and daily diet. This means you can be sure that you are using natural products that are made with the highest standards in mind and ensure your daily well-being.

Yes, the manufacturer is ISO 9001 and ISO 14001 certified. When it comes to the product, the manufacturer meets the quality requirements and quality management systems.

DXN Spica Tea offers a range of benefits for overall health and well-being. From its antioxidant power to its digestive support and stress-relieving properties, this herbal tea can be a valuable addition to a healthy lifestyle.

Ingredients per sachet:
Spica prunellae 2.0g
Pericarpium citri reticulate 1.5g
Herba Manthae 0.5g
Radix glycyrrhizae 0.5g
Ganoderma lucidum 0.5g

Place tea bag in boiling water for 3-5 minutes before serving. One sachet for serving a cup of tea. 1or 2 cup per day.

DXN Spica Tea is produced with ingredients that have been certified as halal or that have Halal Certification, as well as ingredients that fulfil the conditions and follow all the required procedures to be halal-certified.

DXN Spica Tea holds Good Manufacturing Practices (GMP) certification.

DXN Spica Tea continuously assures freshness. We strongly advise you to read the labels and directions for all goods before using them and not to rely only on the information provided by DXN.The relevant authority has not reviewed the product description. This product is not intended to treat, alleviate the effects of, or prevent any disease.

In connection with the judgment of the Court of Justice of the European Union (CJEU) of 30 April 2025 in case C-386/23, we inform you that all data on the health properties resulting from the use of a dietary supplement, including research results and scientific publications, are available on publicly available websites.